| Jay David Geller, MD | |
|
310 Route 24, Suite B1a, Chester, NJ 07930-2625 | |
| (908) 879-8800 | |
| (908) 879-2955 |
| Full Name | Jay David Geller |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 38 Years |
| Location | 310 Route 24, Chester, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548261266 | NPI | - | NPPES |
| 223167652 | Other | NJ | TAXPAYER I.D. |
| 5083401 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 25MA05059400 (New Jersey) | Primary |
| 207ND0900X | Dermatology - Dermatopathology | 25MA05059400 (New Jersey) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jay D Geller Md Pc | 8527166735 | 2 |
News Archive
Throughout the pandemic, health experts have recommended the use of face masks to protect oneself from the virus. Now, the U.S. Centers for Disease Control and Prevention (CDC) stated that the wearing of masks protects not only the wearers but also everyone around them from contracting COVID-19.
USAID is expanding its Indoor Residual Spraying program in Africa, according to a USAID press release. Through a $189 million, three-year contract, "the President's Malaria Initiative … together with the Centers for Disease Control and Prevention will provide technical and financial support to the Ministries of Health and National Malaria Control Programs in African countries to build country-level capacity for malaria prevention activities," according to the release.
Use of antidepressants late in pregnancy has been controversial since the FDA issued a Public Health Advisory in 2006 warning that the use of antidepressants in late pregnancy may increase risk of persistent pulmonary hypertension of the newborn (PPHN), a condition that typically occurs in term or near-term infants and presents within hours of birth with severe respiratory failure requiring intubation and mechanical ventilation.
A new radioimmunotherapy has proven effective in reversing resistance to the most commonly used lymphoma drug, rituximab, according to research published in the October issue of The Journal of Nuclear Medicine.
The Washington Post: Two new studies provide evidence "that the diabetes drug Avandia increases the risk of heart problems and strokes, renewing questions about the safety of the medication. ... The new research, released Monday, should prompt the Food and Drug Administration to remove the drug from the market, according to the researchers who led the analyses and several drug-safety advocates.
› Verified 1 days ago
| Entity Name | Jay D Geller Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629197819 PECOS PAC ID: 8527166735 Enrollment ID: O20070612000675 |
News Archive
Throughout the pandemic, health experts have recommended the use of face masks to protect oneself from the virus. Now, the U.S. Centers for Disease Control and Prevention (CDC) stated that the wearing of masks protects not only the wearers but also everyone around them from contracting COVID-19.
USAID is expanding its Indoor Residual Spraying program in Africa, according to a USAID press release. Through a $189 million, three-year contract, "the President's Malaria Initiative … together with the Centers for Disease Control and Prevention will provide technical and financial support to the Ministries of Health and National Malaria Control Programs in African countries to build country-level capacity for malaria prevention activities," according to the release.
Use of antidepressants late in pregnancy has been controversial since the FDA issued a Public Health Advisory in 2006 warning that the use of antidepressants in late pregnancy may increase risk of persistent pulmonary hypertension of the newborn (PPHN), a condition that typically occurs in term or near-term infants and presents within hours of birth with severe respiratory failure requiring intubation and mechanical ventilation.
A new radioimmunotherapy has proven effective in reversing resistance to the most commonly used lymphoma drug, rituximab, according to research published in the October issue of The Journal of Nuclear Medicine.
The Washington Post: Two new studies provide evidence "that the diabetes drug Avandia increases the risk of heart problems and strokes, renewing questions about the safety of the medication. ... The new research, released Monday, should prompt the Food and Drug Administration to remove the drug from the market, according to the researchers who led the analyses and several drug-safety advocates.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jay David Geller, MD Po Box 399, Chester, NJ 07930-0399 Ph: (908) 879-8800 | Jay David Geller, MD 310 Route 24, Suite B1a, Chester, NJ 07930-2625 Ph: (908) 879-8800 |
News Archive
Throughout the pandemic, health experts have recommended the use of face masks to protect oneself from the virus. Now, the U.S. Centers for Disease Control and Prevention (CDC) stated that the wearing of masks protects not only the wearers but also everyone around them from contracting COVID-19.
USAID is expanding its Indoor Residual Spraying program in Africa, according to a USAID press release. Through a $189 million, three-year contract, "the President's Malaria Initiative … together with the Centers for Disease Control and Prevention will provide technical and financial support to the Ministries of Health and National Malaria Control Programs in African countries to build country-level capacity for malaria prevention activities," according to the release.
Use of antidepressants late in pregnancy has been controversial since the FDA issued a Public Health Advisory in 2006 warning that the use of antidepressants in late pregnancy may increase risk of persistent pulmonary hypertension of the newborn (PPHN), a condition that typically occurs in term or near-term infants and presents within hours of birth with severe respiratory failure requiring intubation and mechanical ventilation.
A new radioimmunotherapy has proven effective in reversing resistance to the most commonly used lymphoma drug, rituximab, according to research published in the October issue of The Journal of Nuclear Medicine.
The Washington Post: Two new studies provide evidence "that the diabetes drug Avandia increases the risk of heart problems and strokes, renewing questions about the safety of the medication. ... The new research, released Monday, should prompt the Food and Drug Administration to remove the drug from the market, according to the researchers who led the analyses and several drug-safety advocates.
› Verified 1 days ago